Bioactive Cyclic Peptides Discovery via SNaPP Bioinformatics

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Traditional methods for discovering novel nonribosomal peptides (NRPs) are time-consuming and inefficient, as they rely on fermentation approaches that require bacterial culture and optimization, often rediscovering known compounds and struggling with cryptic biosynthetic gene clusters and unculturable bacteria, limiting the discovery of bioactive cyclic peptides.

Innovation Solution

The SNaPP method combines bioinformatics tools like antiSMASH and PRISM to predict peptide products from NRPS BGCs, followed by chemical synthesis, prioritizing head-to-tail cyclic peptides catalyzed by PBP-like cyclases, bypassing fermentation and culturing requirements, and focusing on biologically relevant cyclization sites to expedite the discovery of bioactive cyclic peptides.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If traditional fermentation approaches are used to discover NRPs, then bacterial culture and optimization can be performed, but the process becomes time-consuming and inefficient

Engineering Contradiction:
Improvediscovery reliabilityVSAvoiddiscovery time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent applies preliminary action by using bioinformatics tools (antiSMASH, PRISM) to predict peptide products from NRPS BGCs before actual synthesis. This allows researchers to identify potential bioactive peptides computationally and prioritize them for synthesis, bypassing the need for time-consuming fermentation and cultural optimization while maintaining discovery reliability through in silico prediction and validation

Inventive Principle:
Principle #10Preliminary action

2Adaptability or versatility

If fermentation approaches are used, then bacterial culture is possible, but unculturable bacteria and cryptic BGCs cannot be effectively accessed

Engineering Contradiction:
Improveaccessibility to diverse BGCsVSAvoidculturing requirement
Core Design Contradiction:
Adaptability or versatilityVSEase of manufacture

Solution Approach 1:

The patent replaces the mechanical/biological fermentation system with a computational-chemical system. Bioinformatics tools analyze genomic data to predict peptide structures, and chemical synthesis produces the actual compounds. This substitution eliminates the need for bacterial culturing while expanding accessibility to unculturable bacteria and cryptic BGCs that cannot be accessed through traditional fermentation methods

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Quantity of substance

If all predicted peptide products are synthesized, then comprehensive coverage is achieved, but resource efficiency decreases

Engineering Contradiction:
Improvepeptide diversityVSAvoidsynthesis resource consumption
Core Design Contradiction:
Quantity of substanceVSLoss of energy

Solution Approach 1:

The patent applies local quality by prioritizing synthesis of peptides with predicted bioactivity based on structural features and functional predictions from bioinformatics analysis. Instead of synthesizing all predicted peptides equally, the method focuses resources on high-priority candidates identified through computational screening, thereby maintaining peptide diversity while reducing resource consumption through targeted synthesis based on local structural and functional characteristics

Inventive Principle:
Principle #3Local quality

Data Source

PatentUS20240101995A1Bioactive peptide molecules discovered by a combination of bioinformatics technique and chemical synthesis
Publication Date: 2024.03.28 PURDUE RES FOUND
  • US20240101995A1 patent drawing
  • US20240101995A1 patent drawing
  • US20240101995A1 patent drawing

AI summary

The present disclosure teaches a method of treating a patient in need of therapeutic intervention with bioactive cyclic peptide molecules which are useful as antimicrobials, anticancer agents, antiparasitic, immunosuppressants, and others.